Voting Sessions | No. Planned Voting Sessions*, n = 139 | No. Final Voting Sessions, n = 47 | No. Voting Sessions with Consensus, n = 47 |
---|---|---|---|
Final voting sessions | 47 (33.8) | ||
General definition of JIA | 14 (29.8) | 13 (93) | |
Systemic JIA | 12 (25.5) | 5 (41.7) | |
RF-positive JIA | 3 (6.4) | 2 (66.7) | |
Enthesitis/spondylitis-related JIA | 9 (19.1) | 5 (55.6) | |
Early-onset ANA-positive JIA | 2 (4.3) | 2 (100) | |
Other JIA | 1 (2.1) | 1 (100) | |
Unclassified JIA | 1 (2.1) | 1 (100) | |
Other rounds of discussion | |||
Age at onset < 18 yrs | 1 (2.1) | 1 (100) | |
Juvenile PsA | 2 (4.3) | 1 (50) | |
Asymmetric arthritis | 2 (4.3) | 1 (50) | |
Other planned voting sessions discarded and not discussed* | 92 (66.1) | Discarded |
Data are n (%).
↵* The planned electronic voting sessions were prepared by the organizers in excess of the real needs to cover all potential discussion topics. JIA: juvenile idiopathic arthritis; RF: rheumatoid factor; ANA: antinuclear antibody; PsA: psoriatic arthritis.